首页> Pharmaceutics> Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.

Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.

导出 OA

翻译打印收藏纠错

第一作者： Rinda Devi,Bachu

第一单位： College of Pharmacy and Pharmaceutical Sciences, The University of Toledo Health Science Campus, Toledo, OH 43614, USA. RindaDevi.Bachu@rockets.utoledo.edu.

作者： Rinda Devi,Bachu ^[1] ; Pallabitha,Chowdhury ^[2] ; Zahraa H F,Al-Saedi ^[3] ; Pradeep K,Karla ^[4] ; Sai H S,Boddu ^[5]

作者单位： College of Pharmacy and Pharmaceutical Sciences, The University of Toledo Health Science Campus, Toledo, OH 43614, USA. RindaDevi.Bachu@rockets.utoledo.edu. ^[1] College of Pharmacy and Pharmaceutical Sciences, The University of Toledo Health Science Campus, Toledo, OH 43614, USA. Pallabita.Chowdhury@rockets.utoledo.edu. ^[2] College of Pharmacy and Pharmaceutical Sciences, The University of Toledo Health Science Campus, Toledo, OH 43614, USA. ^[3] Department of Pharmaceutical Sciences, College of Pharmacy, Howard University, 2300 4th St. NW, Washington, DC 20059, USA. pkarla@howard.edu. ^[4] College of Pharmacy and Pharmaceutical Sciences, The University of Toledo Health Science Campus, Toledo, OH 43614, USA. sboddu@utnet.utoledo.edu. ^[5]

关键词 anterior segment disposition novel drug delivery systems polymeric nanocarriers toxicity

DOI 10.3390/pharmaceutics10010028

PMID 29495528

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交